GVR Report cover Next Generation Sequencing Market Size, Share & Trends Report

Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (Targeted Sequencing & Resequencing), By Product, By Application, By Workflow, By End-use, By Region And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-428-4
  • Number of Report Pages: 300
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2022
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Next Generation Sequencing Market Trends

The global next generation sequencing market size was estimated at USD 8.40 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 21.7% 2024 to 2030. Next Generation Sequencing (NGS) refers to the huge DNA sequencing methods that aid in genomic discovery. Following the World Health Organization's (WHO) declaration of COVID-19 as a pandemic, a diverse group of recognized pharmaceutical and biotechnology companies, have decided to step forward in order to boost the global research efforts to develop test kits and vaccines.

U.S. next generation sequencing market size and growth rate, 2024 - 2030

Furthermore, major companies across the globe have increased their research and development capacities. This substantial focus on COVID-19 vaccine development offered a lucrative opportunity for the adoption of NGS during the pandemic period. For instance, a group of researchers in China utilized MinION Mk1C, a product by Oxford Nanopore Technologies (U.K.) for the sequencing of COVID-19 samples. In addition, factors such as extensive adoption of NGS technologies in clinical diagnostics due to rapid result time and faster processing are also projected to offer a favorable environment for market growth during the forecast period. For instance, in August 2020, Pediatrix Medical Group, GeneDx Inc., and OPKO Health signed an agreement to provide state-of-the-art, next generation gene-sequencing to enhance clinical diagnosis in uncommon disorders for newborn intensive care units.

Moreover, growing technological developments in NGS instruments and technologies are further likely to offer significant market growth over the coming years. For instance, in January 2020, the Intelligence Advanced Research Projects Activity in the U.S. awarded a grant of USD 23 million to the Harvard University, DNA Script, and Broad Institute. The institutes are conducting collaborative research to develop a novel technology that will combine enzymatic DNA synthesis and NGS into a single instrument.

To better understand the link between genetics and disease, several countries have invested in their own national population genome mapping projects. Furthermore, millions of genomes are being sequenced by government groups to progress research and discover better ways to identify and cure cancer, uncommon disorders, and other ailments. Efforts are being undertaken by the EU to improve the region’s large-scale genomic data with projects such as France’s French Plan for Genomic Medicine 2025 and the UK’s 100,000 Genomes Project. Such initiatives have resulted in the growth of NGS informatics services in the region.

Certain advantages offered by NGS such as cost-effectiveness, rapid and accurate sample analysis, and technological advancements are estimated to boost the adoption of NGS technologies during the forecast period. In addition, the development of genomics programs in a number of countries is projected to benefit the NGS market. The advent of next generation sequencing-based diagnoses, along with proactive government support, are also some of the key market growth factors.

The NGS market is experiencing lucrative growth, propelled by the increasing demand for testing and services worldwide. NGS testing has become instrumental in genomics research, clinical diagnostics, and personalized medicine, driving the expansion of the market. NGS data analysis, a critical component in deriving meaningful insights from vast genomic datasets, has witnessed a surge in demand, further fueling market growth.

As researchers and healthcare professionals seek comprehensive solutions, NGS services, including sequencing and data interpretation, are becoming necessary. The advent of NGS panels, designed for targeted sequencing of specific genomic regions, has revolutionized genetic analysis, offering cost-effective and efficient solutions for various applications. The synergy between advancements in NGS technologies and the increasing awareness of their potential across diverse sectors ensures a promising future for the NGS market, focusing on its pivotal role in shaping the future of genomics and precision medicine.

Top of Form

Market Concentration & Characteristics

Market growth for next generation sequencing market is high and pace is accelerating. One of the most important factors expected to have a significant impact on NGS is how much and to what extent the growth of personalized medicine would enhance the adoption of this technology in the next 7 years. The exponentially decreasing cost of sequencing whole genomes with subsequent technological advancements in precision medicine in a way replicates Moore’s law for semiconductors in the field of life sciences. NGS is anticipated to witness high demand for applications in clinical diagnostics over the forecast period.

Key strategies opted by the companies in the next generation sequencing market include increased spending on R&D, collaborations and product launches.  For instance, in In February 2022, Invitae Corporation announced the launch of LiquidPlex Dx and FusionPlex Dx in Europe. It allows genomic profiling along with companion diagnostics used for solid tumor neoplasms. These are used on Illumina's Next Generation Sequencing platforms for IVD testing.

Next Generation Sequencing Market Concentration & Characteristics

The NGS market has high impact of regulations. In the U.S., a clinical laboratory accreditation is required to be obtained by the CMS with certification in compliance with CLIA for conducting genetic & diagnostic tests, such as the New York State Department of Health and College of American Pathologists.

North America and Europe are witnessing rapid clinical developments in NGS methodologies for applications in oncology and infectious diseases. Presence of market leaders, such as Illumina, Roche, and Life Technologies, which are involved in the development of rapid and high-throughput sequencing capabilities, has contributed to the country’s market growth. These players are undertaking several strategic initiatives to strengthen their market presence in the country. For instance, in February 2022, Agilent Technologies, Inc. partnered with Element Biosciences, Inc. to integrate the latter’s AVITI System with Agilent’s SureSelect target enrichment panels for enhancing customer access to genomic tools.

Application Insights

The oncology segment held the highest market share of 27.70% in 2023. A gradually growing prevalence of cancer that warrants use of latest technology to enable oncologists better understand the mechanics of cancer and tumor cells and the application of NGS for DNA & RNA sequencing, epigenetics, and analyzing chromosomal abnormalities account for over three fourths of the global sequencing data are factors responsible for high market share. Companies like Myriad, through its myRisk product, offer genetic testing to identify people who may be at higher risk of developing certain cancers in the future. In January 2021, Merus N.V.; a clinical stage immuno-oncology company; collaborated with National Cancer Center, Japan and Erasmus University Medical Center, Netherlands to evaluate its HER2/3-targeting bispecific antibody in solid tumors.

Furthermore, the consumer genomics segment is anticipated to be the fastest-growing segment with a CAGR of 24.84% during the forecast period. Continuous introduction of new products by the key players is driving growth in the consumer genomics segment. Presence of companies such as 23andMe that are involved in the provision of the “Personal Genome Service” can be attributed to growth in the coming years. Moreover, Ancestry.com, Color Genomics, Cloud Health (which purchased a HiSeq X Ten), National Geographic and several Japanese consumer companies, as well as a nascent consumer business, Helix, which was launched by Illumina are expected to impact revenue generation in this segment. Rapid proliferation in genealogy, paternity testing, and personal health awareness is expected to drive the growth in the consumer genomics, as an application of NGS.

Product Insights

The consumables segment held the larger market share in 2023 and will continue to grow at a faster CAGR of 22.47% from 2024 to 2030. The larger share and exponential growth rate of this segment is mainly attributed to the recurrent usage and high demand of the consumables in the commercial as well as research applications of NGS. These consumables include sample preparation kits as well as kits for target enrichment. The adoption of NGS consumables has increased as most of the pharmaceutical companies and research institutes are utilizing NGS for several diagnostic applications and cancer research.

Another import factor contributing to the growth of the consumables market is the involvement of key companies in development of innovative products, focus on regulatory approvals, along with strategic initiatives to ensure the constant supply of consumables that can meet the increasing demand. These efforts also strengthen the company’s product portfolio, thus, maintaining the leading position in the market. For instance, in June 2022, PerkinElmer, Inc. launched three sample preparation kits for research purpose only, which include PG-Seq Rapid Kit v2, NEXTFLEX Small RNA-Seq Kit v4, and NEXTFLEX Rapid XP V2 DNA-Seq Kit. All these factors along with increasing R&D activities in the sequencing market will continue to boost the market growth.

Technology Insights

The targeted sequencing & resequencing segment held the highest market share in 2023. This segment is expected to witness growth in demand subsequent to the growth of whole genome sequencing, as the availability of a large amount of whole genome data will required to be analyzed at specific gene locations and isolated genetic expressions. There are many companies in the NGS market offering targeted sequencing services. Thus, this segment is expected to grow in tandem with WGS segment throughout the forecast period.

Illumina offers targeted resequencing with its gene panel and array finder, whereas Pacific Biosciences of California’s Sequel System with its SMRT technique allows targeted sequencing and accurate detection of variants. Targeted sequencing panels are expected to remain the workhorse for cancer molecular diagnostics and are projected to become the routine part of the heme malignancies and solid tumor.

Workflow Insights

The sequencing segment held the highest market share in 2023. NGS sequencing is the most important phase of the workflow and consequently accounts for the largest share of the market. These systems are able to provide accurate amount of liquid, which is important in NGS. Moreover, functions such as changing tubes and micro liter plates are also carried out by the system, which helps streamline workflow. The advantage of using robotic liquid handling system is that it enables researchers focus on analyzing the data rather than managing the process.

NGS Data Analysis is anticipated to be the fastest growing segment with a CAGR of 22.89%. A key factor contributing to the industry growth is the growing acceptance of sequencing platforms for clinical diagnosis due to a huge cost reduction of installation. Moreover, easy genomic and proteomic information availability is anticipated to create significant growth opportunities in this industry during the forecast period. Furthermore, the cost reduction of these sequencing technologies has resulted in increased adoption of NGS. In addition strategic activities by key market players will further offer lucrative opportunities in the review period. For instance, Illumina's BaseSpace Suite, aids in the analysis of sequencing data and the production of findings in a short amount of time. To expand its data analytic capabilities, the company has also purchased DRAGEN Bio-IT Platform (DRAGEN) and Edico Genome. Furthermore, Genomatix and DNAnexus, provide cloud-based solutions for the interpretation and management of enormous volumes of sequencing data.

End use Insights

The academic research segment held the highest market share in 2023. Application of NGS solutions in research projects that are carried out in the universities and research centers can be attributed to the largest share of this segment in the market. Furthermore, scholarships offered for PhD projects in NGS are anticipated to drive demand for NGS products and services, thereby resulting in lucrative growth over the forecast period. Provision of on-site bioinformatics courses that include workshops on practical implementation of NGS sequencing and data analysis are also expected to boost revenue generated through academic research segment in the coming years.

Global next generation sequencing market share and size, 2023

Clinical research segment is anticipated to be the fastest growing segment with a CAGR of 22.92% during the forecast period. Owing to the use of NGS in cancer research and, more specifically, in discovery of new cancer-related genes, studying tumor heterogeneity, and identification of alterations that are contributive in tumorigenesis the segment is expected to witness significant growth through to 2030. In addition, availability of clinical research solutions through market entities such as Illumina, Thermo Fisher Scientific Corporation, and Agilent Technologies for the purpose of target enrichment & detection is anticipated to provide this segment with high growth opportunities over the forecast period.

Regional Insights

North America dominated the NGS market with a share of 49.25% in 2023. The regional market is driven by the presence of multiple clinical laboratories that employ NGS to provide genetic testing services. Furthermore, due to the presence of high R&D investment, availability of technologically advanced healthcare research framework, the development of WGS in the region is also expected to serve as a critical factor for the growth of North America NGS market throughout the forecast period.

Next Generation Sequencing Market Trends, by Region, 2024 - 2030

The Asia Pacific region is estimated to be the fastest-growing region owing to the presence of significant developments by China and Japan for technological integration of NGS methodologies, and the development of healthcare, R&D and clinical development frameworks of emerging economies such as India and Australia have poised the Asia Pacific NGS market to witness lucrative opportunities o growth throughout the forecast period.

UK Next Generation Sequencing Market

The UK next-generation sequencing market is expected to grow in tandem with the overall European market owing to increase in development of companion diagnostics and subsequent establishment of molecular diagnostic development facilities by key market players. Furthermore, ongoing strategic alliances between players in European and eastern markets are expected to fuel growth of next generation sequencing market during the forecast period in the region.

Key Companies & Market Share Insights

Major companies in the market are focusing on new product launches to cater the growing demand from various end users. Furthermore, emerging companies re involved into collaboration and partnerships with market leaders to increase their footprint in the competitive market space.

Key Next Generation Sequencing Companies:

  • Illumina
  • F. Hoffman-La Roche Ltd.
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies
  • PierianDx
  • Genomatix GmbH
  • DNASTAR, Inc.
  • Perkin Elmer, Inc.
  • Eurofins GATC Biotech GmbH
  • BGI

Recent Developments

  • In December 2023, Oxford Nanopore launched TurBOT beta access in partnership with Tecan. The buyers are expected to recive the products in Q1 2024. TurBOT  is a benchtop instrument offering efficient basecalling, data analysis, automated extraction, and library preparation of multiple samples in one single unit.

  • In December 2023, Illumina signed a memorandum of understanding with African Society for Laboratory Medicine to increase access to genomics within the African region to fight infectious diseases.

  • In December 2023, Illumina partnered with HaploX to provide locally manufactured sequencing instruments in China.

  • In November 2023, MedGenome and PacBio announced De Novo Genome Assembly and Annotation grant. Such research grants are expected to promote research and development activities within the industry.

  • In November 2023, Yourgene Health and PacBio announced collaboration in order to optimize the workflow of long read sequencing. PacBio approved LightBench instrument made by Yourgene Health for size selection of long DNA fragments

  • In September 2023, Integrated DNA Technologies (IDT) launched its xGen NGS products, including primers, adapters, and universal blockers for the Ultima Genomics UG 100 platform

Next Generation Sequencing Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 10.16 billion

Revenue forecast in 2030

USD 33.15 billion

Growth rate

CAGR of 21.66% from 2023 to 2030

Actual data

2018 - 2023

Forecast period

2024 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2023 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Technology, product, application, workflow, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

Illumina; QIAGEN; Thermo Fisher Scientific, Inc.; F. Hoffman-La Roche Ltd.; Oxford Nanopore Technologies; Genomatix GmbH; PierianDx; DNASTAR, Inc.; Eurofins GATC Biotech GmbH; Perkin Elmer, Inc.; BGI; Bio-Rad Laboratories, Inc.

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Next Generation Sequencing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the next generation sequencing market on the basis of technology, product, application, workflow, end-use, and region.

  • Technology Outlook (Revenue, USD Million, 2018 - 2030)

    • WGS

    • Whole Exome Sequencing

    • Targeted Sequencing & Resequencing

      • DNA-based

      • RNA-based

    • Others

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Platform

      • Sequencing

      • Data Analysis

    • Consumables

      • Sample Preparation

      • Target Enrichment

      • Others

  • Application Outlook (Revenue, USD Million, 2018 - 2030)

    • Oncology

      • Diagnostics and Screening

        • Oncology Screening

          • Sporadic Cancer

          • Inherited Cancer

        • Companion Diagnostics

        • Other Diagnostics

      • Research Studies

    • Clinical Investigation

      • Infectious Diseases

      • Inherited Diseases

      • Idiopathic Diseases

      • Non-Communicable/Other Diseases

    • Reproductive Health

      • NIPT

        • Aneuploidy

        • Microdeletions

      • PGT

      • Newborn Genetic Screening

      • Single Gene Analysis

    • HLA Typing/Immune System Monitoring

    • Metagenomics, Epidemiology & Drug Development

    • Agrigenomics & Forensics

    • Consumer Genomics

  • Workflow Outlook (Revenue, USD Million, 2018 - 2030)

    • Pre-Sequencing

      • NGS Library Preparation Kits

      • Semi-automated Library Preparation

      • Automated Library Preparation

    • Sequencing

    • NGS Data Analysis

      • NGS Primary Data Analysis

      • NGS Secondary Data Analysis

      • NGS Tertiary Data Analysis

  • End-use Outlook (Revenue, USD Million, 2018 - 2030)

    • Academic Research

    • Clinical Research

    • Hospitals & Clinics

    • Pharma & Biotech Entities

    • Other Users

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • South Korea

      • Australia

      • Thailand

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

Table of Contents

Chapter 1. Next Generation Sequencing Market: Methodology and Scope
                   1.1. Market Segmentation and Scope
                   1.2. Regional Scope
                   1.3. Estimates and Forecast Timeline
                   1.4. Objective
                   1.5. Research Methodology
                   1.6. Information Procurement
                       1.6.1. Purchased Database
                       1.6.2. GVR’s Internal Database
                       1.6.3. Secondary Sources
                       1.6.4. Primary Research
                   1.7. Information or Data Analysis
                       1.7.1. Data Analysis Models
                   1.8. Market Formulation & Validation
                   1.9. Model Details
                       1.9.1. Commodity Flow Analysis
                   1.10. List of Secondary Sources
                   1.11. List of Abbreviations
Chapter 2. Next Generation Sequencing Market: Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. Next Generation Sequencing Market: Variables, Trends & Scope
                   3.1. Market Segmentation and Scope
                   3.2. Market Lineage Outlook
                       3.2.1. Parent Market Outlook
                       3.2.2. Related/Ancillary Market Outlook
                   3.3. Market Trends and Outlook
                   3.4. Market Dynamics
                       3.4.1. Exponentially decreasing costs for genetic sequencing
                       3.4.2. Development of companion diagnostics and personalized medicine
                       3.4.3. Rise in competition among prominent market entities
                       3.4.4. Rising clinical opportunity for NGS technology
                       3.4.5. Technological advancements in cloud computing and data integration
                       3.4.6. Growing healthcare expenditure supporting development of effective diagnostic & therapeutic procedures for cancer
                       3.4.7. Increasing prevalence of cancer
                   3.5. Market Restraint Analysis
                       3.5.1. Lack of computational efficiency for data management
                       3.5.2. Non–value-based NGS reimbursement policy and regulation status
                       3.5.3. Challenges associated with NGS implementation.
                   3.6. Market Analysis Tools
                       3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
                       3.6.2. Porter’s Five Forces Analysis
                       3.6.3. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
                   4.1. Next Generation Sequencing Data Analysis Market: Technology Movement Analysis
                   4.2. Targeted sequencing & resequencing
                       4.2.1. Targeted Sequencing & Resequencing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       4.2.2. DNA-based targeted sequencing & resequencing
                           4.2.2.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
                       4.2.3. RNA-based targeted sequencing & resequencing
                           4.2.3.1. RNA -based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
                   4.3. Whole genome sequencing
                       4.3.1. Whole Genome Sequencing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   4.4. Whole exome sequencing
                       4.4.1. Whole Exome Sequencing Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 5. Product Business Analysis
                   5.1. Next Generation Sequencing Data Analysis Market: Product Movement Analysis
                   5.2. Platforms
                       5.2.1. Platforms Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       5.2.2. Sequencing
                           5.2.2.1. Sequencing Platforms Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       5.2.3. Data Analysis
                           5.2.3.1. Data Analysis Platforms Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   5.3. Consumables
                       5.3.1. Consumables Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       5.3.2. Sample Preparation
                           5.3.2.1. Sample Preparation Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       5.3.3. Target Enrichment
                           5.3.3.1. Target Enrichment Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       5.3.4. Others
                           5.3.4.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
                   6.1. Next Generation Sequencing Data Analysis Market: Application Movement Analysis
                   6.2. Oncology
                       6.2.1. Oncology Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.2.2. Diagnostics & Screening
                           6.2.2.1. Diagnostics & Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
                           6.2.2.2. Oncology screening
                               6.2.2.2.1. Oncology Screening Market Estimates and Forecast, 2018 - 2030 (USD Million)
                               6.2.2.2.2. Sporadic Cancer Screening Market Estimates and Forecast, 2018 - 2030 (USD Million)
                               6.2.2.2.3. Inherited Cancer Screening Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           6.2.2.3. Companion diagnostics
                               6.2.2.3.1. Companion Diagnostics Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           6.2.2.4. Other Diagnostics
                               6.2.2.4.1. Other Diagnostics Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.2.3. Research Studies
                           6.2.3.1. Research Studies Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   6.3. Clinical Investigation
                       6.3.1. Clinical Investigation Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.3.2. Infectious Diseases
                           6.3.2.1. Infectious Diseases Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.3.3. Idiopathic Diseases
                           6.3.3.1. Idiopathic Diseases Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.3.4. Inherited Diseases
                           6.3.4.1. Inherited Diseases Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.3.5. Non-communicable/other Diseases
                           6.3.5.1. Reproductive Health Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   6.4. Reproductive Health
                       6.4.1. Clinical Investigation Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.4.2. NIPT
                           6.4.2.1. NIPT Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           6.4.2.2. Aneuploidy
                               6.4.2.2.1. Aneuploidy Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           6.4.2.3. Microdeletions
                               6.4.2.3.1. Microdeletions Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.4.3. PGT
                           6.4.3.1. PGT Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.4.4. Newborn Genetic Screening
                           6.4.4.1. Newborn Genetic Screening Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.4.5. Single Gene Analysis Market
                           6.4.5.1. Single Gene Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   6.5. HLA Typing/Immune System Monitoring
                       6.5.1. HLA Typing/Immune System Monitoring Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   6.6. Metagenomics, Epidemiology & Drug Development
                       6.6.1. Metagenomics, Epidemiology & Drug Development Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   6.7. Agrigenomics & Forensics
                       6.7.1. Agrigenomics & Forensics Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   6.8. Consumer Genomics
                       6.8.1. Consumer Genomics Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 7. Workflow Business Analysis
                   7.1. Next Generation Sequencing Data Analysis Market: Workflow Movement Analysis
                   7.2. Presequencing
                       7.2.1. Presequencing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           7.2.1.1. NGS Library Preparation Kits
                               7.2.1.1.1. NGS Library Preparation Kits Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           7.2.1.2. Semiautomated Library Preparation
                               7.2.1.2.1. Semiautomated Library Preparation Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           7.2.1.3. Automated Library Preparation
                               7.2.1.3.1. Automated Library Preparation Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   7.3. Sequencing
                       7.3.1. Sequencing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   7.4. Data Analysis
                       7.4.1. Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       7.4.2. Primary Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           7.4.2.1. Primary Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       7.4.3. Secondary Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           7.4.3.1. Secondary Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       7.4.4. Tertiary Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           7.4.4.1. Tertiary Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 8. End - Use Business Analysis
                   8.1. Next Generation Sequencing Market: End - Use Movement Analysis
                   8.2. Academic Research
                       8.2.1. Academic Research Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   8.3. Clinical Research
                       8.3.1. Clinical Research Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   8.4. Hospitals & Clinics
                       8.4.1. Hospitals & Clinics Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   8.5. Pharmaceutical & Biotech Entities
                       8.5.1. Pharmaceutical & Biotech Entities Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   8.6. Other Users
                       8.6.1. Other Users Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 9. Regional Business Analysis
                   9.1. Next Generation Sequencing Market Share By Region, 2022 & 2030
                   9.2. North America
                       9.2.1. SWOT Analysis
                       9.2.2. North America next generation sequencing market, 2018 - 2030 (USD Million)
                       9.2.3. U.S.
                           9.2.3.1. Key country dynamics
                           9.2.3.2. U.S. next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.3.3. Target disease prevalence
                           9.2.3.4. Competitive scenario
                           9.2.3.5. Regulatory framework
                           9.2.3.6. Reimbursement scenario
                       9.2.4. Canada
                           9.2.4.1. Key country dynamics
                           9.2.4.2. Canada next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.4.3. Target disease prevalence
                           9.2.4.4. Competitive scenario
                           9.2.4.5. Regulatory framework
                           9.2.4.6. Reimbursement scenario
                       9.2.5. Europe
                       9.2.6. SWOT Analysis
                       9.2.7. Europe Next Generation Sequencing market, 2018 - 2030 (USD Million)
                       9.2.8. Germany
                           9.2.8.1. Key country dynamics
                           9.2.8.2. Germany next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.8.3. Target disease prevalence
                           9.2.8.4. Competitive scenario
                           9.2.8.5. Regulatory framework
                           9.2.8.6. Reimbursement scenario
                       9.2.9. UK
                           9.2.9.1. Key country dynamics
                           9.2.9.2. UK next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.9.3. Target disease prevalence
                           9.2.9.4. Competitive scenario
                           9.2.9.5. Regulatory framework
                           9.2.9.6. Reimbursement scenario
                       9.2.10. France
                           9.2.10.1. Key country dynamics
                           9.2.10.2. France next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.10.3. Target disease prevalence
                           9.2.10.4. Competitive scenario
                           9.2.10.5. Regulatory framework
                           9.2.10.6. Reimbursement scenario
                       9.2.11. Italy
                           9.2.11.1. Key country dynamics
                           9.2.11.2. Italy next generation sequencing (NGS) market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.11.3. Target disease prevalence
                           9.2.11.4. Competitive scenario
                           9.2.11.5. Regulatory framework
                           9.2.11.6. Reimbursement scenario
                       9.2.12. Spain
                           9.2.12.1. Key country dynamics
                           9.2.12.2. Spain next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.12.3. Target disease prevalence
                           9.2.12.4. Competitive scenario
                           9.2.12.5. Regulatory framework
                           9.2.12.6. Reimbursement scenario
                       9.2.13. Denmark
                           9.2.13.1. Key country dynamics
                           9.2.13.2. Denmark next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.13.3. Target disease prevalence
                           9.2.13.4. Competitive scenario
                           9.2.13.5. Regulatory framework
                           9.2.13.6. Reimbursement scenario
                       9.2.14. Sweden
                           9.2.14.1. Key country dynamics
                           9.2.14.2. Sweden next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.14.3. Target disease prevalence
                           9.2.14.4. Competitive scenario
                           9.2.14.5. Regulatory framework
                           9.2.14.6. Reimbursement scenario
                       9.2.15. Norway
                           9.2.15.1. Key country dynamics
                           9.2.15.2. Norway next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.15.3. Target disease prevalence
                           9.2.15.4. Competitive scenario
                           9.2.15.5. Regulatory framework
                           9.2.15.6. Reimbursement scenario
                   9.3. Asia Pacific
                       9.3.1. SWOT Analysis
                       9.3.2. Asia Pacific next generation sequencing market, 2018 - 2030 (USD Million)
                       9.3.3. Japan
                           9.3.3.1. Key country dynamics
                           9.3.3.2. Japan next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.3.3.3. Target disease prevalence
                           9.3.3.4. Competitive scenario
                           9.3.3.5. Regulatory framework
                           9.3.3.6. Reimbursement scenario
                       9.3.4. China
                           9.3.4.1. Key country dynamics
                           9.3.4.2. China next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.3.4.3. Target disease prevalence
                           9.3.4.4. Competitive scenario
                           9.3.4.5. Regulatory framework
                           9.3.4.6. Reimbursement scenario
                       9.3.5. India
                           9.3.5.1. Key country dynamics
                           9.3.5.2. India next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.3.5.3. Target disease prevalence
                           9.3.5.4. Competitive scenario
                           9.3.5.5. Regulatory framework
                           9.3.5.6. Reimbursement scenario
                       9.3.6. South Korea
                           9.3.6.1. Key country dynamics
                           9.3.6.2. South Korea next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.3.6.3. Target disease prevalence
                           9.3.6.4. Competitive scenario
                           9.3.6.5. Regulatory framework
                           9.3.6.6. Reimbursement scenario
                       9.3.7. Australia
                           9.3.7.1. Key country dynamics
                           9.3.7.2. Australia next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.3.7.3. Target disease prevalence
                           9.3.7.4. Competitive scenario
                           9.3.7.5. Regulatory framework
                           9.3.7.6. Reimbursement scenario
                       9.3.8. Thailand
                           9.3.8.1. Key country dynamics
                           9.3.8.2. Thailand next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.3.8.3. Target disease prevalence
                           9.3.8.4. Competitive scenario
                           9.3.8.5. Regulatory framework
                           9.3.8.6. Reimbursement scenario
                   9.4. Latin America
                       9.4.1. SWOT Analysis
                       9.4.2. Latin America next generation sequencing market, 2018 - 2030 (USD Million)
                       9.4.3. Brazil
                           9.4.3.1. Key country dynamics
                           9.4.3.2. Brazil next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.4.3.3. Target disease prevalence
                           9.4.3.4. Competitive scenario
                           9.4.3.5. Regulatory framework
                           9.4.3.6. Reimbursement scenario
                       9.4.4. Mexico
                           9.4.4.1. Key country dynamics
                           9.4.4.2. Mexico next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.4.4.3. Target disease prevalence
                           9.4.4.4. Competitive scenario
                           9.4.4.5. Regulatory framework
                           9.4.4.6. Reimbursement scenario
                       9.4.5. Argentina
                           9.4.5.1. Key country dynamics
                           9.4.5.2. Argentina next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.4.5.3. Target disease prevalence
                           9.4.5.4. Competitive scenario
                           9.4.5.5. Regulatory framework
                           9.4.5.6. Reimbursement scenario
                   9.5. MEA
                       9.5.1. SWOT Analysis
                       9.5.2. MEA next generation sequencing market, 2018 - 2030 (USD Million)
                       9.5.3. South Africa
                           9.5.3.1. Key country dynamics
                           9.5.3.2. South Africa next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.5.3.3. Target disease prevalence
                           9.5.3.4. Competitive scenario
                           9.5.3.5. Regulatory framework
                           9.5.3.6. Reimbursement scenario
                       9.5.4. Saudi Arabia
                           9.5.4.1. Key country dynamics
                           9.5.4.2. Saudi Arabia next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.5.4.3. Target disease prevalence
                           9.5.4.4. Competitive scenario
                           9.5.4.5. Regulatory framework
                           9.5.4.6. Reimbursement scenario
                       9.5.5. UAE
                           9.5.5.1. Key country dynamics
                           9.5.5.2. UAE next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.5.5.3. Target disease prevalence
                           9.5.5.4. Competitive scenario
                           9.5.5.5. Regulatory framework
                           9.5.5.6. Reimbursement scenario
                       9.5.6. Kuwait
                           9.5.6.1. Key country dynamics
                           9.5.6.2. Kuwait next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.5.6.3. Target disease prevalence
                           9.5.6.4. Competitive scenario
                           9.5.6.5. Regulatory framework
                           9.5.6.6. Reimbursement scenario
Chapter 10. Competitive Landscape
                   10.1. Participant’s Overview
                   10.2. Company Categorization
                   10.3. Financial Performance
                   10.4. Product Benchmarking
                   10.5. Company Market Share Analysis
                   10.6. Strategy Mapping
                       10.6.1. THERMO FISHER SCIENTIFIC, INC.
                           10.6.1.1. Overview
                           10.6.1.2. Life Technologies Corporation
                               10.6.1.2.1. Overview
                           10.6.1.3. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.1.4. Product Benchmarking
                           10.6.1.5. Strategic Initiatives
                       10.6.2. QIAGEN N.V
                           10.6.2.1. Overview
                           10.6.2.2. CLC Bio
                               10.6.2.2.1. Overview
                           10.6.2.3. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.2.4. Product Benchmarking
                           10.6.2.5. Strategic Initiatives
                       10.6.3. Illumina, Inc.
                           10.6.3.1. Overview
                           10.6.3.2. Edico Genome
                               10.6.3.2.1. Overview
                           10.6.3.3. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.3.4. Product Benchmarking
                           10.6.3.5. Strategic Initiatives
                       10.6.4. F. Hoffmann-La Roche Ltd
                           10.6.4.1. Overview
                           10.6.4.2. Foundation Medicine
                               10.6.4.2.1. Overview
                           10.6.4.3. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.4.4. Product Benchmarking
                           10.6.4.5. Strategic Initiatives
                       10.6.5. Agilent Technologies, Inc.
                           10.6.5.1. Overview
                           10.6.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.5.3. Product Benchmarking
                           10.6.5.4. Strategic Initiatives
                       10.6.6. Bio-Rad Laboratories, Inc.
                           10.6.6.1. Overview
                           10.6.6.2. GnuBio
                               10.6.6.2.1. Overview
                           10.6.6.3. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.6.4. Product Benchmarking
                           10.6.6.5. Strategic Initiatives
                       10.6.7. PierianDx
                           10.6.7.1. Overview
                           10.6.7.2. Tute Genomics
                           10.6.7.2.1. GnuBio
                               10.6.7.2.2. Knome, Inc
                                   10.7.7.2.2.1 COMPANY OVERVIEW
                           10.6.7.3. Product Benchmarking
                           10.6.7.4. Strategic Initiatives
                       10.6.8. Oxford Nanopore Technologies Plc
                           10.6.8.1. Overview
                           10.6.8.2. Product Benchmarking
                           10.6.8.3. Strategic Initiatives
                       10.6.9. Partek Incorporated
                           10.6.9.1. Overview
                           10.6.9.2. Product Benchmarking
                           10.6.9.3. Strategic Initiatives
                       10.6.10. Eurofins Scientific
                           10.6.10.1. Overview
                           10.6.10.2. Eurofins GATC Biotech GmbH
                               10.6.10.2.1. Overview
                           10.6.10.3.
                           10.6.10.4. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.10.5. Product Benchmarking
                           10.6.10.6. Strategic Initiatives
                       10.6.11. DNASTAR, Inc.
                           10.6.11.1. Overview
                           10.6.11.2. Product Benchmarking
                           10.6.11.3. Strategic Initiatives
                       10.6.12. SOPHIA GENETICS
                           10.6.12.1. Overview
                           10.6.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.12.3. Product Benchmarking
                           10.6.12.4. Strategic Initiatives
                       10.6.13. Fabric Genomics, Inc.
                           10.6.13.1. Overview
                           10.6.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.13.3. Product Benchmarking
                           10.6.13.4. Strategic Initiatives
                       10.6.14. Laboratory Corporation of America
                           10.6.14.1. Overview
                           10.6.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.14.3. Product Benchmarking
                           10.6.14.4. Strategic Initiatives
                       10.6.15. SYAPSE, INC.
                           10.6.15.1. Overview
                           10.6.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.15.3. Product Benchmarking
                           10.6.15.4. Strategic Initiatives
                           10.6.16. IQVIA
                           10.6.16.1. Overview
                           10.6.16.2. Q² Solutions
                           10.6.16.2.1. Overview
                           10.6.16.3. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.16.4. Product Benchmarking
                           10.6.16.5. Strategic Initiatives
                       10.6.17. Personalis, Inc
                           10.6.17.1. Overview
                           10.6.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.17.3. Product Benchmarking
                           10.6.17.4. Strategic Initiatives
                       10.6.18. 10x Genomics
                           10.6.18.1. Overview
                           10.6.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.18.3. Product Benchmarking
                           10.6.18.4. Strategic Initiatives
                       10.6.19. DNAnexus, Inc
                           10.6.19.1. Overview
                           10.6.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.19.3. Product Benchmarking
                           10.6.19.4. Strategic Initiatives
                       10.6.20. CENTOGENE N.V
                           10.6.20.1. Overview
                           10.6.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.20.3. Product Benchmarking
                           10.6.20.4. Strategic Initiatives
                       10.6.21. Invitae Corporation
                           10.6.21.1. Overview
                           10.6.21.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.21.3. Product Benchmarking
                           10.6.21.4. Strategic Initiatives
                       10.6.22. GeneDx, LLC
                           10.6.22.1. Overview
                           10.6.22.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.22.3. Product Benchmarking
                           10.6.22.4. Strategic Initiatives


List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Country share estimation
Table 4. Healthcare expenditure, 2022
Table 5. NGS top platforms
Table 6. Base pairs sequenced using WGS, WES, and targeted sequencing & resequencing
Table 7. Clonal amplification products in the market
Table 8. North America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 9. North America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 10. North America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 11. North America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 12. North America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 13. North America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 14. North America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 15. North America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 16. North America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 17. North America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 18. North America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 19. North America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 20. North America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 21. U.S. next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 22. U.S. next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 23. U.S. next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 24. U.S. next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 25. U.S. NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 26. U.S. NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 27. U.S. next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 28. U.S. next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 29. U.S. targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 30. U.S. next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 31. U.S. NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 32. U.S. NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 33. U.S. next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 34. Canada next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 35. Canada next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 36. Canada next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 37. Canada next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 38. Canada NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 39. Canada NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 40. Canada next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 41. Canada next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 42. Canada targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 43. Canada next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 44. Canada NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 45. Canada NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 46. Canada next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47. Europe next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 48. Europe next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 49. Europe next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 50. Europe next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 51. Europe NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 52. Europe NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 53. Europe next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 54. Europe next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 55. Europe targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 56. Europe next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 57. Europe NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 58. Europe NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 59. Europe next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 60. Germany next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 61. Germany next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 62. Germany next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 63. Germany next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 64. Germany NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 65. Germany NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 66. Germany next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 67. Germany next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 68. Germany targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 69. Germany next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 70. Germany NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 71. Germany NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 72. Germany next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 73. U.K. next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 74. U.K. next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 75. U.K. next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 76. U.K. next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 77. U.K. NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 78. U.K. NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 79. U.K. next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 80. U.K. next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 81. U.K. targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 82. U.K. next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 83. U.K. NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 84. U.K. NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 85. U.K. next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 86. Spain next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 87. Spain next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 88. Spain next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 89. Spain next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 90. Spain NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 91. Spain NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 92. Spain next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 93. Spain next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 94. Spain targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 95. Spain next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 96. Spain NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 97. Spain NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 98. Spain next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 99. France next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 100. France next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 101. France next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 102. France next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 103. France NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 104. France NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 105. France next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 106. France next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 107. France targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 108. France next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 109. France NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 110. France NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 111. France next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 112. Italy next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 113. Italy next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 114. Italy next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 115. Italy next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 116. Italy NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 117. Italy NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 118. Italy next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 119. Italy next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 120. Italy targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 121. Italy next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 122. Italy NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 123. Italy NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 124. Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 125. Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 126. Denmark next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 127. Denmark next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 128. Denmark next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 129. Denmark next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 130. Denmark NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 131. Denmark NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 132. Denmark next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 133. Denmark next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 134. Denmark targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 135. Denmark next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 136. Denmark NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 137. Denmark NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 138. Denmark next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 139. Norway next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 140. Norway next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 141. Norway next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 142. Norway next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 143. Norway NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 144. Norway NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 145. Norway next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 146. Norway next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 147. Norway targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 148. Norway next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 149. Norway NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 150. Norway NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 151. Norway next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 152. Sweden next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 153. Sweden next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 154. Sweden next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 155. Sweden next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 156. Sweden NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 157. Sweden NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 158. Sweden next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 159. Sweden next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 160. Sweden targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 161. Sweden next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 162. Sweden NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 163. Sweden NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 164. Sweden next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 165. Asia Pacific next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 166. Asia Pacific next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 167. Asia Pacific next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 168. Asia Pacific next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 169. Asia Pacific NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 170. Asia Pacific NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 171. Asia Pacific next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 172. Asia Pacific next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 173. Asia Pacific targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 174. Asia Pacific next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 175. Asia Pacific NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 176. Asia Pacific NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 177. Asia Pacific next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 178. Japan next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 179. Japan next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 180. Japan next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 181. Japan next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 182. Japan NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 183. Japan NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 184. Japan next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 185. Japan next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 186. Japan targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 187. Japan next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 188. Japan NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 189. Japan NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 190. Japan next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 191. China next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 192. China next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 193. China next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 194. China next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 195. China NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 196. China NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 197. China next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 198. China next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 199. China targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 200. China next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 201. China NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 202. China NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 203. China next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 204. India next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 205. India next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 206. India next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 207. India next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 208. India NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 209. India NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 210. India next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 211. India next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 212. India targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 213. India next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 214. India NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 215. India NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 216. India next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 217. South Korea next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 218. South Korea next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 219. South Korea next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 220. South Korea next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 221. South Korea NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 222. South Korea NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 223. South Korea next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 224. South Korea next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 225. South Korea targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 226. South Korea next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 227. South Korea NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 228. South Korea NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 229. South Korea next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 230. Australia next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 231. Australia next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 232. Australia next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 233. Australia next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 234. Australia NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 235. Australia NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 236. Australia next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 237. Australia next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 238. Australia targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 239. Australia next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 240. Australia NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 241. Australia NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 242. Australia next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 243. Thailand next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 244. Thailand next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 245. Thailand next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 246. Thailand next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 247. Thailand NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 248. Thailand NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 249. Thailand next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 250. Thailand next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 251. Thailand targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 252. Thailand next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 253. Thailand NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 254. Thailand NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 255. Thailand next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 256. Latin America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 257. Latin America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 258. Latin America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 259. Latin America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 260. Latin America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 261. Latin America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 262. Latin America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 263. Latin America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 264. Latin America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 265. Latin America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 266. Latin America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 267. Latin America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 268. Latin America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 269. Brazil next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 270. Brazil next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 271. Brazil next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 272. Brazil next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 273. Brazil NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 274. Brazil NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 275. Brazil next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 276. Brazil next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 277. Brazil targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 278. Brazil next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 279. Brazil NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 280. Brazil NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 281. Brazil next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 282. Mexico next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 283. Mexico next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 284. Mexico next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 285. Mexico next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 286. Mexico NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 287. Mexico NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 288. Mexico next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 289. Mexico next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 290. Mexico targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 291. Mexico next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 292. Mexico NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 293. Mexico NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 294. Mexico next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 295. Argentina next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 296. Argentina next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 297. Argentina next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 298. Argentina next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 299. Argentina NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 300. Argentina NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 301. Argentina next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 302. Argentina next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 303. Argentina targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 304. Argentina next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 305. Argentina NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 306. Argentina NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 307. Argentina next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 308. MEA next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 309. MEA next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 310. MEA next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 311. MEA next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 312. MEA NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 313. MEA NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 314. MEA next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 315. MEA next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 316. MEA targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 317. MEA next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 318. MEA NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 319. MEA NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 320. MEA next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 321. South Africa next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 322. South Africa next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 323. South Africa next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 324. South Africa next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 325. South Africa NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 326. South Africa NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 327. South Africa next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 328. South Africa next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 329. South Africa targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 330. South Africa next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 331. South Africa NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 332. South Africa NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 333. South Africa next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 334. Saudi Arabia next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 335. Saudi Arabia next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 336. Saudi Arabia next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 337. Saudi Arabia next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 338. Saudi Arabia NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 339. Saudi Arabia NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 340. Saudi Arabia next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 341. Saudi Arabia next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 342. Saudi Arabia targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 343. Saudi Arabia next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 344. Saudi Arabia NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 345. Saudi Arabia NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 346. Saudi Arabia next generation sequencing market estimates & forecasts, by end--use, 2018 - 2030 (USD Million)
Table 347. UAE next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 348. UAE next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 349. UAE next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 350. UAE next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 351. UAE NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 352. UAE NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 353. UAE next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 354. UAE next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 355. UAE targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 356. UAE next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 357. UAE NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 358. UAE NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 359. UAE next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 360. Kuwait next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 361. Kuwait next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 362. Kuwait next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 363. Kuwait next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 364. Kuwait NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 365. Kuwait NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 366. Kuwait next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 367. Kuwait next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 368. Kuwait targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 369. Kuwait next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 370. Kuwait NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 371. Kuwait NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 372. Kuwait next generation sequencing market estimates & forecasts, by end--use, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Next Generation Sequencing, Market Segmentation
Fig. 8 Market Snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
Fig. 16 Global Next Generation Sequencing Market: Product Movement Analysis
Fig. 17 Global Next Generation Sequencing Market, for Platforms, 2018 - 2030 (USD Million)
Fig. 18 Global Next Generation Sequencing Market, for Sequencing, 2018 - 2030 (USD Million)
Fig. 19 Global Next Generation Sequencing Market, for Data Analysis, 2018 - 2030 (USD Million)
Fig. 20 Global Next Generation Sequencing Market, for Consumables, 2018 - 2030 (USD Million)
Fig. 21 Global Next Generation Sequencing Market, for Sample Preparation, 2018 - 2030 (USD Million)
Fig. 22 Global Next Generation Sequencing Market, for Target Enrichment, 2018 - 2030 (USD Million)
Fig. 23 Global Next Generation Sequencing Market: Application, Movement Analysis
Fig. 24 Global Next Generation Sequencing Market, for Oncology, 2018 - 2030 (USD Million)
Fig. 25 Global Next Generation Sequencing Market, for Diagnostics & Screening, 2018 - 2030 (USD Million)
Fig. 26 Global Next Generation Sequencing Market, for Screening, 2018 - 2030 (USD Million)
Fig. 27 Global Next Generation Sequencing Market, for Sporadic Cancer, 2018 - 2030 (USD Million)
Fig. 28 Global Next Generation Sequencing Market, for Inherited Cancer, 2018 - 2030 (USD Million)
Fig. 29 Global Next Generation Sequencing Market, for Companion Diagnostics, 2018 - 2030 (USD Million)
Fig. 30 Global Next Generation Sequencing Market, for Other Diagnostics, 2018 - 2030 (USD Million)
Fig. 31 Global Next Generation Sequencing Market, for Research Studies, 2018 - 2030 (USD Million)
Fig. 32 Global Next Generation Sequencing Market, for Clinical Investigation, 2018 - 2030 (USD Million)
Fig. 33 Global Next Generation Sequencing Market for Infectious Diseases 2018 - 2030 (USD Million)
Fig. 34 Global Next Generation Sequencing Market, for Idiopathic Diseases, 2018 - 2030 (USD Million)
Fig. 35 Global Next Generation Sequencing Market, for Inherited Diseases, 2018 - 2030 (USD Million)
Fig. 36 Global Next Generation Sequencing Market, for Non-Communicable/Other Diseases, 2018 - 2030 (USD Million)
Fig. 37 Global Next Generation Sequencing Market, for Reproductive Health, 2018 - 2030 (USD Million)
Fig. 38 Global Next Generation Sequencing Market, for NIPT, 2018 - 2030 (USD Million)
Fig. 39 Global Next Generation Sequencing Market for Aneuploidy, 2018 - 2030 (USD Million)
Fig. 40 Global Next Generation Sequencing Market, for Microdeletions, 2018 - 2030 (USD Million)
Fig. 41 Global Next Generation Sequencing Market, for PGT, 2018 - 2030 (USD Million)
Fig. 42 Global Next Generation Sequencing Market for Newborn Genetic Screening, 2018 - 2030 (USD Million)
Fig. 43 Global Next Generation Sequencing Market, for Single Gene Analysis, 2018 - 2030 (USD Million)
Fig. 44 Global Next Generation Sequencing Market, for HLA Typing/Immune System Monitoring, 2018 - 2030 (USD Million)
Fig. 45 Global Next Generation Sequencing Market, for Metagenomics, Epidemiology & Drug Development, 2018 - 2030 (USD Million)
Fig. 46 Global Next Generation Sequencing Market for Agrigenomics & Forensics, 2018 - 2030 (USD Million)
Fig. 47 Global Next Generation Sequencing Market, for Consumer Genomics, 2018 - 2030 (USD Million)
Fig. 48 Global Next Generation Sequencing Market: Technology Movement Analysis
Fig. 49 Global Next Generation Sequencing Market for Whole Genome Sequencing, 2018 - 2030 (USD Million)
Fig. 50 Global Next Generation Sequencing Market, for Whole Exome Sequencing, 2018 - 2030 (USD Million)
Fig. 51 Global Next Generation Sequencing Market, for Targeted Sequencing & Resequencing, 2018 - 2030 (USD Million)
Fig. 52 Global Next Generation Sequencing Market, for DNA-based, 2018 - 2030 (USD Million)
Fig. 53 Global Next Generation Sequencing Market for RNA-based, 2018 - 2030 (USD Million)
Fig. 54 Global Next Generation Sequencing Market: Workflow Movement Analysis
Fig. 55 Global Next Generation Sequencing Market, for Pre-Sequencing, 2018 - 2030 (USD Million)
Fig. 56 Global Next Generation Sequencing Market, for Library Preparation, 2018 - 2030 (USD Million)
Fig. 57 Global Next Generation Sequencing Market for NGS Library Preparation Kits, 2018 - 2030 (USD Million)
Fig. 58 Global Next Generation Sequencing Market for Semi-automated Library Preparation, 2018 - 2030 (USD Million)
Fig. 59 Global Next Generation Sequencing Market for Automated Library Prepartion, 2018 - 2030 (USD Million)
Fig. 60 Global Next Generation Sequencing Market for Others, 2018 - 2030 (USD Million)
Fig. 61 Global Next Generation Sequencing Market for Sequencing, 2018 - 2030 (USD Million)
Fig. 62 Global Next Generation Sequencing Market for NGS Data Analysis, 2018 - 2030 (USD Million)
Fig. 63 Global Next Generation Sequencing Market for NGS Primary Data Analysis, 2018 - 2030 (USD Million)
Fig. 64 Global Next Generation Sequencing Market for NGS Secondary Data Analysis, 2018 - 2030 (USD Million)
Fig. 65 Global Next Generation Sequencing Market for NGS Tertiary Data Analysis, 2018 - 2030 (USD Million)
Fig. 66 Global Next Generation Sequencing Market: End-use Movement Analysis
Fig. 67 Global Next Generation Sequencing Market for Academic Research, 2018 - 2030 (USD Million)
Fig. 68 Global Next Generation Sequencing Market for Clinical Research, 2018 - 2030 (USD Million)
Fig. 69 Global Next Generation Sequencing Market for Hospitals & Clinics, 2018 - 2030 (USD Million)
Fig. 70 Global Next Generation Sequencing Market for Pharma & Biotech Entities, 2018 - 2030 (USD Million)
Fig. 71 Global Next Generation Sequencing Market for Other users, 2018 - 2030 (USD Million)
Fig. 72 Regional Marketplace: Key Takeaways Other users
Fig. 73 Regional Outlook, 2022 & 2030
Fig. 74 Global Next Generation Sequencing Market: Region Movement Analysis
Fig. 75 North America Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 76 U.S. Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 77 Canada Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 78 Europe Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 79 Germany Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 80 UK Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 81 France Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 82 Italy Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 83 Spain Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 84 Denmark Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 85 Sweden Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 86 Norway Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 87 Asia Pacific Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 88 Japan Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 89 China Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 90 India Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 91 South Korea Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 92 Australia Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 93 Thailand Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 94 Latin America Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 95 Brazil Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 96 Mexico Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 97 Argentina Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 98 Middle East and Africa Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 99 South Africa Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 100 Saudi Arabia Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 101 UAE Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 102 Kuwait Next Generation Sequencing Market, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Market Segmentation

  • Global Next Generation Sequencing Market, By Technology, (Revenue, USD Million, 2018 - 2030)
    • WGS
    • Whole Exome Sequencing
    • Targeted Sequencing & Resequencing
      • DNA-based
      • RNA-based
    • Others
  • Global Next Generation Sequencing Market, By Product, (Revenue, USD Million, 2018 - 2030)
    • Platform
      • Sequencing
      • Data Analysis
    • Consumables
      • Sample Preparation
      • Target Enrichment
      • Others
  • Global Next Generation Sequencing Market, By Application, (Revenue, USD Million, 2018 - 2030)
    • Oncology
      • Diagnostics and Screening
        • Oncology Screening
          • Sporadic Cancer
          • Inherited Cancer
        • Companion Diagnostics
        • Other Diagnostics
      • Research Studies
    • Clinical Investigation
      • Infectious Diseases
      • Inherited Diseases
      • Idiopathic Diseases
      • Non-Communicable/Other Diseases
    • Reproductive Health
      • NIPT
        • Aneuploidy
        • Microdeletions
      • PGT
      • Newborn Genetic Screening
      • Single Gene Analysis
    • HLA Typing/Immune System Monitoring
    • Metagenomics, Epidemiology & Drug Development
    • Agrigenomics & Forensics
    • Consumer Genomics
  • Global Next Generation Sequencing Market, By Workflow, (Revenue, USD Million, 2018 - 2030)
    • Pre-Sequencing
      • NGS Library Preparation Kits
      • Semi-automated Library Preparation
      • Automated Library Preparation
    • Sequencing
    • NGS Data Analysis
      • NGS Primary Data Analysis
      • NGS Secondary Data Analysis
      • NGS Tertiary Data Analysis
  • Global Next Generation Sequencing Market, By End-use, (Revenue, USD Million, 2018 - 2030)
    • Academic Research
    • Clinical Research
    • Hospitals & Clinics
    • Pharma & Biotech Entities
    • Other Users
  • Global Next Generation Sequencing: Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Next Generation Sequencing Market, By Technology
        • WGS
        • Whole Exome Sequencing
        • Targeted Sequencing & Resequencing
          • DNA-based
          • RNA-based
        • Others
      • North America Next Generation Sequencing Market, By Product
        • Platform
          • Sequencing
          • Data Analysis
        • Consumables
          • Sample Preparation
          • Target Enrichment
          • Others
      • North America Next Generation Sequencing Market, By Application Type 
        • Oncology
          • Diagnostics and Screening
            • Oncology Screening
              • Sporadic Cancer
              • Inherited Cancer
            • Companion Diagnostics
            • Other Diagnostics
          • Research Studies
        • Clinical Investigation
          • Infectious Diseases
          • Inherited Diseases
          • Idiopathic Diseases
          • Non-Communicable/Other Diseases
        • Reproductive Health
          • NIPT
            • Aneuploidy
            • Microdeletions
          • PGT
          • Newborn Genetic Screening
          • Single Gene Analysis
        • HLA Typing/Immune System Monitoring
        • Metagenomics, Epidemiology & Drug Development
        • Agrigenomics & Forensics
        • Consumer Genomics
      • North America Next Generation Sequencing Market, By Workflow
        • Pre-Sequencing
          • NGS Library Preparation Kits
          • Semi-automated Library Preparation
          • Automated Library Preparation
        • Sequencing
        • NGS Data Analysis
          • NGS Primary Data Analysis
          • NGS Secondary Data Analysis
          • NGS Tertiary Data Analysis
      • North America Next Generation Sequencing Market, By End-use
        • Academic Research
        • Clinical Research
        • Hospitals & Clinics
        • Pharma & Biotech Entities
        • Other Users
      • U.S.
        • U.S. Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • U.S. Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • U.S. Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • U.S. Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • U.S. Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • Canada
        • Canada Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Canada Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Canada Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Canada Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Canada Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
    • Europe
      • Europe Next Generation Sequencing Market, By Technology
        • WGS
        • Whole Exome Sequencing
        • Targeted Sequencing & Resequencing
          • DNA-based
          • RNA-based
        • Others
      • Europe Next Generation Sequencing Market, By Product
        • Platform
          • Sequencing
          • Data Analysis
        • Consumables
          • Sample Preparation
          • Target Enrichment
          • Others
      • Europe Next Generation Sequencing Market, By Application Type 
        • Oncology
          • Diagnostics and Screening
            • Oncology Screening
              • Sporadic Cancer
              • Inherited Cancer
            • Companion Diagnostics
            • Other Diagnostics
          • Research Studies
        • Clinical Investigation
          • Infectious Diseases
          • Inherited Diseases
          • Idiopathic Diseases
          • Non-Communicable/Other Diseases
        • Reproductive Health
          • NIPT
            • Aneuploidy
            • Microdeletions
          • PGT
          • Newborn Genetic Screening
          • Single Gene Analysis
        • HLA Typing/Immune System Monitoring
        • Metagenomics, Epidemiology & Drug Development
        • Agrigenomics & Forensics
        • Consumer Genomics
      • Europey Next Generation Sequencing Market, By Workflow
        • Pre-Sequencing
          • NGS Library Preparation Kits
          • Semi-automated Library Preparation
          • Automated Library Preparation
        • Sequencing
        • NGS Data Analysis
          • NGS Primary Data Analysis
          • NGS Secondary Data Analysis
          • NGS Tertiary Data Analysis
      • Europe Next Generation Sequencing Market, By End-use
        • Academic Research
        • Clinical Research
        • Hospitals & Clinics
        • Pharma & Biotech Entities
        • Other Users
      • Germany
        • Germany Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Germany Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Germany Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Germany Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Germany Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • UK
        • UK Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • UK Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • UK Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • UK Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • UK Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • France
        • France Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • France Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • France Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • France Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • France Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • Italy
        • Italy Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Italy Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Italy Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Italy Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Italy Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • Spain
        • Spain Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Spain Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Spain Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Spain Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Spain Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • Denmark
        • Denmark Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Denmark Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Denmark Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Denmark Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Denmark Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • Sweden
        • Sweden Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Sweden Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Sweden Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Sweden Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Sweden Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • Norway
        • Norway Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Norway Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Norway Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Norway Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Norway Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
    • Asia Pacific
      • Asia Pacific Next Generation Sequencing Market, By Technology
        • WGS
        • Whole Exome Sequencing
        • Targeted Sequencing & Resequencing
          • DNA-based
          • RNA-based
        • Others
      • Asia Pacific Next Generation Sequencing Market, By Product
        • Platform
          • Sequencing
          • Data Analysis
        • Consumables
          • Sample Preparation
          • Target Enrichment
          • Others
      • Asia Pacific Next Generation Sequencing Market, By Application Type 
        • Oncology
          • Diagnostics and Screening
            • Oncology Screening
              • Sporadic Cancer
              • Inherited Cancer
            • Companion Diagnostics
            • Other Diagnostics
          • Research Studies
        • Clinical Investigation
          • Infectious Diseases
          • Inherited Diseases
          • Idiopathic Diseases
          • Non-Communicable/Other Diseases
        • Reproductive Health
          • NIPT
            • Aneuploidy
            • Microdeletions
          • PGT
          • Newborn Genetic Screening
          • Single Gene Analysis
        • HLA Typing/Immune System Monitoring
        • Metagenomics, Epidemiology & Drug Development
        • Agrigenomics & Forensics
        • Consumer Genomics
      • Asia Pacific Next Generation Sequencing Market, By Workflow
        • Pre-Sequencing
          • NGS Library Preparation Kits
          • Semi-automated Library Preparation
          • Automated Library Preparation
        • Sequencing
        • NGS Data Analysis
          • NGS Primary Data Analysis
          • NGS Secondary Data Analysis
          • NGS Tertiary Data Analysis
      • Asia Pacific Next Generation Sequencing Market, By End-use
        • Academic Research
        • Clinical Research
        • Hospitals & Clinics
        • Pharma & Biotech Entities
        • Other Users
      • Japan
        • Japan Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Japan Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Japan Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Japan Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Japan Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • China
        • China Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • China Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • China Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • China Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • China Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • India
        • India Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • India Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • India Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • India Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • India Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • South Korea
        • South Korea Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • South Korea Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • South Korea Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • South Korea Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • South Korea Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • Australia
        • Australia Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Australia Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Australia Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Australia Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Australia Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • Thailand
        • Thailand Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Thailand Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Thailand Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Thailand Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Thailand Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
    • Latin America
      • Latin America Next Generation Sequencing Market, By Technology
        • WGS
        • Whole Exome Sequencing
        • Targeted Sequencing & Resequencing
          • DNA-based
          • RNA-based
        • Others
      • Latin America Next Generation Sequencing Market, By Product
        • Platform
          • Sequencing
          • Data Analysis
        • Consumables
          • Sample Preparation
          • Target Enrichment
          • Others
      • Latin America Next Generation Sequencing Market, By Application Type 
        • Oncology
          • Diagnostics and Screening
            • Oncology Screening
              • Sporadic Cancer
              • Inherited Cancer
            • Companion Diagnostics
            • Other Diagnostics
          • Research Studies
        • Clinical Investigation
          • Infectious Diseases
          • Inherited Diseases
          • Idiopathic Diseases
          • Non-Communicable/Other Diseases
        • Reproductive Health
          • NIPT
            • Aneuploidy
            • Microdeletions
          • PGT
          • Newborn Genetic Screening
          • Single Gene Analysis
        • HLA Typing/Immune System Monitoring
        • Metagenomics, Epidemiology & Drug Development
        • Agrigenomics & Forensics
        • Consumer Genomics
      • Latin America Next Generation Sequencing Market, By Workflow
        • Pre-Sequencing
          • NGS Library Preparation Kits
          • Semi-automated Library Preparation
          • Automated Library Preparation
        • Sequencing
        • NGS Data Analysis
          • NGS Primary Data Analysis
          • NGS Secondary Data Analysis
          • NGS Tertiary Data Analysis
      • Latin America Next Generation Sequencing Market, By End-use
        • Academic Research
        • Clinical Research
        • Hospitals & Clinics
        • Pharma & Biotech Entities
        • Other Users
      • Brazil
        • Brazil Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Brazil Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Brazil Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Brazil Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Brazil Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • Mexico
        • Mexico Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Mexico Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Mexico Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Mexico Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Mexico Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • Argentina
        • Argentina Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Argentina  Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Argentina Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Argentina Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Argentina Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
    • Middle East & Africa
      • Middle East & Africa Next Generation Sequencing Market, By Technology
        • WGS
        • Whole Exome Sequencing
        • Targeted Sequencing & Resequencing
          • DNA-based
          • RNA-based
        • Others
      • Middle East & Africa Next Generation Sequencing Market, By Product
        • Platform
          • Sequencing
          • Data Analysis
        • Consumables
          • Sample Preparation
          • Target Enrichment
          • Others
      • Middle East & Africa Next Generation Sequencing Market, By Application Type 
        • Oncology
          • Diagnostics and Screening
            • Oncology Screening
              • Sporadic Cancer
              • Inherited Cancer
            • Companion Diagnostics
            • Other Diagnostics
          • Research Studies
        • Clinical Investigation
          • Infectious Diseases
          • Inherited Diseases
          • Idiopathic Diseases
          • Non-Communicable/Other Diseases
        • Reproductive Health
          • NIPT
            • Aneuploidy
            • Microdeletions
          • PGT
          • Newborn Genetic Screening
          • Single Gene Analysis
        • HLA Typing/Immune System Monitoring
        • Metagenomics, Epidemiology & Drug Development
        • Agrigenomics & Forensics
        • Consumer Genomics
      • Middle East & Africa Next Generation Sequencing Market, By Workflow
        • Pre-Sequencing
          • NGS Library Preparation Kits
          • Semi-automated Library Preparation
          • Automated Library Preparation
        • Sequencing
        • NGS Data Analysis
          • NGS Primary Data Analysis
          • NGS Secondary Data Analysis
          • NGS Tertiary Data Analysis
      • Middle East & Africa Next Generation Sequencing Market, By End-use
        • Academic Research
        • Clinical Research
        • Hospitals & Clinics
        • Pharma & Biotech Entities
        • Other Users
      • South Africa
        • South Africa Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • South Africa Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • South Africa Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • South Africa Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • South Africa Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • Saudi Arabia
        • Saudi Arabia Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Saudi Arabia Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Saudi Arabia Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Saudi Arabia Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Saudi Arabia Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • UAE
        • UAE Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • UAE Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • UAE  Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • UAE Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • UAE Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users
      • Kuwait
        • Kuwait Next Generation Sequencing Market, By Technology
          • WGS
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
            • DNA-based
            • RNA-based
          • Others
        • Kuwait Next Generation Sequencing Market, By Product
          • Platform
            • Sequencing
            • Data Analysis
          • Consumables
            • Sample Preparation
            • Target Enrichment
            • Others
        • Kuwait Next Generation Sequencing Market, By Application Type 
          • Oncology
            • Diagnostics and Screening
              • Oncology Screening
                • Sporadic Cancer
                • Inherited Cancer
              • Companion Diagnostics
              • Other Diagnostics
            • Research Studies
          • Clinical Investigation
            • Infectious Diseases
            • Inherited Diseases
            • Idiopathic Diseases
            • Non-Communicable/Other Diseases
          • Reproductive Health
            • NIPT
              • Aneuploidy
              • Microdeletions
            • PGT
            • Newborn Genetic Screening
            • Single Gene Analysis
          • HLA Typing/Immune System Monitoring
          • Metagenomics, Epidemiology & Drug Development
          • Agrigenomics & Forensics
          • Consumer Genomics
        • Kuwait Next Generation Sequencing Market, By Workflow
          • Pre-Sequencing
            • NGS Library Preparation Kits
            • Semi-automated Library Preparation
            • Automated Library Preparation
          • Sequencing
          • NGS Data Analysis
            • NGS Primary Data Analysis
            • NGS Secondary Data Analysis
            • NGS Tertiary Data Analysis
        • Kuwait Next Generation Sequencing Market, By End-use
          • Academic Research
          • Clinical Research
          • Hospitals & Clinics
          • Pharma & Biotech Entities
          • Other Users

Next Generation Sequencing Market Dynamics

Driver: Exponentially Decreasing Costs For Genetic Sequencing

The cost of genetic sequencing has been significantly coming down over the recent years. The cost of sequencing data is dependent upon different platforms and services being used. There has been an exponential decrease in the price of sequencing an entire human genome. This price reduction will significantly benefit the genome sequencing adoption, thereby significantly boosting its demand. With the introduction of new advanced algorithms, it is anticipated that NGS data can be converted into medically actionable reports by reducing its computational complexity. Key market players are putting in continuous efforts to develop a cost-efficient test for genome sequencing. For instance, in February 2020, Nebula Genomics launched an at-home WGS test for the price of USD 299.

Driver: Technological Advancements In Cloud Computing And Data Integration

To process NGS-generated data, the introduction of cloud computing environment has played a significant role in driving the NGS data analysis market. Cloud computing is cost-effective for data analysis and provides a reasonable performance. However smaller firms & research entities cannot afford the services and infrastructure for implementation of cloud computing. Hence, companies such as Google, Microsoft, and Amazon provide computational power for storage and analysis of this data. Several companies are involved in providing services of workflow and data management for genome sequencing data on the Amazon cloud. With technological advancements, data integration tools have also improved through advent of cloud computing to analyze & process massive NGS sequenced data. This improvement in technology is anticipated to boost the market in the coming years.

Restraint: Challenges Associated With Ngs Implementation

Although NGS has paved a way for clinical research, handling the abundant data generated from NGS still presents a significant challenge. The biological sequences need to be compressed in such a way that they can be easily stored and accessed. Referential compression schemes are being developed to compress the data; however, scalability and compression rate are the main challenges associated with it. Managing quality scores along with the sequence compression is another important factor in implementation of upcoming technology, which is expected to restrain market growth to certain extent. Moreover, referential compression integration within a short time and string search in novel workflows are other challenges that can hinder the growth of the market.

What Does This Report Include?

This section will provide insights into the contents included in this next generation sequencing market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Next generation sequencing market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Next generation sequencing market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Research Methodology

A three-pronged approach was followed for deducing the next generation sequencing market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for next generation sequencing market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of next generation sequencing market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Next Generation Sequencing Market Categorization:

The next generation sequencing market was categorized into six segments, namely technology (WGS, Whole Exome Sequencing, Targeted Sequencing & Resequencing), product (Platform, Consumables), application (Oncology, Clinical Investigation, Reproductive Health, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, Consumer Genomics), workflow (Pre-Sequencing, Sequencing, NGS Data Analysis), end-use (Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Other Users), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The next generation sequencing market was segmented into technology, product, application, workflow, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The next generation sequencing market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Next generation sequencing market companies & financials:

The next generation sequencing market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Thermo Fisher Scientific, Inc.: Thermo Fisher Scientific, Inc. is a publicly held biotechnology company established after the collaboration of Thermo Electron and Fisher Scientific. The company provides products in life sciences, industrial & applied sciences, and clinical diagnostics. Thermo Fisher offers products through the following brands: Thermo Scientific, Invitrogen, Applied Biosystems, Fisher Scientific, and Unity Lab Services.

  • Qiagen N.V.: QIAGEN N.V. is a biotechnology company. The key business areas of Qiagen N.V. include assay technologies for molecular diagnostics, pharmaceutical, academic, and applied testing. Molecular technologies developed by the company are being utilized by forensic technicians and the company is also involved in isolation of genetic material from biological samples.

  • Illumina, Inc. - Illumina, Inc. develops, manufactures, and distributes integrated platforms and systems for sequencing. It also performs analysis and investigation of genomic & proteomic information, determination of biological function, and expression of gene sequences. The company provides NGS platforms for genotyping, sequencing, and gene expression analysis.

  • F. Hoffmann-La Roche Ag - F. Hoffmann-La Roche AG is involved in development and manufacture of diagnostic & pharmaceutical products. It is divided into two segments: pharmaceuticals and diagnostics. Roche sequencing (454 Life Sciences) is a subsidiary of Roche Diagnostics Corporation.

  • AGILENT TECHNOLOGIES, INC. - The company has operations in pharmaceuticals, food, chemical & energy, environmental & forensics, and research segments. The company’s diagnostics & genomics business includes companion diagnostics, nucleic acid contract manufacturing & pathology, genomics, and reagent partnership businesses. Its genomics portfolio includes genotyping, DNA methylation profiling, identification of gene rearrangements, gene expression profiling, gene copy number determination, arrays for DNA mutation detection, NGS target enrichment, and genetic data management & interpretation support software.

  • Bio-Rad Laboratories, Inc. - Bio-Rad Laboratories, Inc. provides tools and services for life science research, food science, and clinical diagnostics markets. It offers solutions to advance scientific research & development and for introduction of new technology in the fields of proteomics, genomics, food safety, medical diagnostics, drug discovery, and more.

  • PIERIANDX - PierianDx is involved in development and distribution of products for personalized medicine. It offers a workspace for genomic testing and provides a data-driven ecosystem for clinical labs.

  • Oxford Nanopore Technologies Plc - The company was established as Oxford NanoLabs Ltd. and was renamed in 2008. It specializes in the development of nanopore-based electronic systems for sensing biological molecules. The company operates across various verticals, such as personalized medicines, scientific research, crop science, environmental applications, security, and defense.

  • Partek Incorporated – Partek Inc. designs software for statistical analysis in genomics utilized by researchers for DNA microarray, bioinformatics, interactive data visualization, nextgeneration sequencing data, and bioinformatics. It is a software analysis company established in 1993.

  • Eurofins Scientific - Eurofins Scientific offers testing services to the environmental, food, and pharmaceutical industries. The company also serves as a CRO in the agro science sector and is one of the leading players in certain laboratory & testing services for discovery pharmacology, forensics, genomics, advanced material sciences, and support clinical studies.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Next Generation Sequencing Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2023, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Next Generation Sequencing Market Report Assumptions:

  • The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
Jump to content
pdf icn

GET A FREE SAMPLE

arrow icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Or view our licence options:

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.